Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05638581Phase 3Completed
A Phase 3 trial of low-titer group O whole blood in hemorrhagic shock, sponsored by University of Alabama at Birmingham. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05638581.